Evaluation of bone markers in hypophosphatemic rickets/osteomalacia

Endocrine

Volumn 40, Issue 2, 2011, Pages 315-317

  Nagata, Yuki ^a   Imanishi, Yasuo ^a   Ishii, Akira ^a   Kurajoh, Masafumi ^a   Motoyama, Koka ^a   Morioka, Tomoaki ^a   Naka, Hiroshi ^a   Mori, Katsuhito ^a   Miki, Takami ^a   Emoto, Masanori ^a   Inaba, Masaaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Oncogenic osteomalacia; PINP; Tumor induced osteomalacia; X linked hypophosphatemic rickets

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

ADULT; ARTICLE; BONE MATRIX; BONE MINERALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; MALE; ONCOGENIC OSTEOMALACIA; OSSIFICATION; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; X LINKED HYPOPHOSPHATEMIC RICKETS;

EID: 84855195744     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9512-z     Document Type: Article

References (10)

1. Y. Imanishi, M. Inaba, K. Nakatsuka, K. Nagasue, S. Okuno, A. Yoshihara, M. Miura, A. Miyauchi, K. Kobayashi, T. Miki, T. Shoji, E. Ishimura, Y. Nishizawa, FGF-23 in patients with endstage renal disease on hemodialysis. Kidney Int. 65(5), 1943-1946 (2004) (Pubitemid 38591047)
2. Y. Imanishi, M. Inaba, T. Kawata, Y. Nishizawa, Animal models of hyperfunctioning parathyroid diseases for drug development. Expert Opin. Drug Discov. 4(7), 727-740 (2009)
3. K.B. Jonsson, R. Zahradnik, T. Larsson, K.E. White, T. Sugimoto, Y. Imanishi, T. Yamamoto, G. Hampson, H. Koshiyama, O. Ljunggren, K. Oba, I.M. Yang, A. Miyauchi, M.J. Econs, J. Lavigne, H. Juppner, Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N. Engl. J. Med. 348(17), 1656-1663 (2003) (Pubitemid 36459471)
4. B. Demiaux, M.E. Arlot, M.C. Chapuy, P.J. Meunier, P.D. Delmas, Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J. Clin. Endocrinol. Metab. 74(5), 1146-1151 (1992)
5. E.D. Daniels, J.M. Pettifor, G.P. Moodley, Serum osteocalcin has limited usefulness as a diagnostic marker for rickets. Eur. J. Pediatr. 159(10), 730-733 (2000)
6. I. Ros, L. Alvarez, N. Guanabens, P. Peris, A. Monegal, I. Vazquez, D. Cerda, A.M. Ballesta, J. Munoz-Gomez, Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J. Bone Miner. Metab. 23(3), 266-269 (2005) (Pubitemid 40603211)
7. R.M. Harrell, K.W. Lyles, J.M. Harrelson, N.E. Friedman, M.K. Drezner, Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J. Clin. Invest. 75(6), 1858-1868 (1985) (Pubitemid 15237795)
8. I.R. Reid, W.A. Murphy, D.C. Hardy, S.L. Teitelbaum, M.A. Bergfeld, M.P. Whyte, X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. Am. J. Med. 90(1), 63-69 (1991)
9. G.S. Stein, J.B. Lian, Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14(4), 424-442 (1993) (Pubitemid 23238925)
10. K. Hollberg, R. Marsell, M. Norgard, T. Larsson, K.B. Jonsson, G. Andersson, Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice. Bone 42(6), 1111-1121 (2008)